Cowealth Medical China Co.Ltd. (603122) — Capital Reinvestment Ratio
Cowealth Medical China Co.Ltd. (603122) has a Capital Reinvestment Ratio of 0.80x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.68 Million) in capital expenditures (CN¥14.21 Million). Check Cowealth Medical China Co.Ltd. (603122) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cowealth Medical China Co.Ltd. Capital Reinvestment Ratio (2020–2025)
This chart tracks Cowealth Medical China Co.Ltd.'s Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Cowealth Medical China Co.Ltd..
Annual Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. from 2020 to 2025. See Cowealth Medical China Co.Ltd. (603122) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | CN¥17.68 Million | CN¥14.21 Million | ▲ +235.2% |
| 2024 | 0.24x | CN¥132.75 Million | CN¥31.82 Million | ▼ -96.0% |
| 2023 | 6.02x | CN¥11.28 Million | CN¥67.96 Million | ▲ +90.9% |
| 2021 | 3.16x | CN¥7.01 Million | CN¥22.12 Million | ▲ +2785.6% |
| 2020 | 0.11x | CN¥74.15 Million | CN¥8.11 Million | — |